Norepinephrine Bitartrate Patent Expiration

Norepinephrine Bitartrate is Used for increasing blood pressure in adult patients with severe, acute hypotension. It was first introduced by Hospira Inc in its drug Levophed on Approved Prior to Jan 1, 1982. Other drugs containing Norepinephrine Bitartrate are Norepinephrine Bitartrate In 5% Dextrose, Norepinephrine Bitartrate In 0.9% Sodium Chloride. 17 different companies have introduced drugs containing Norepinephrine Bitartrate.


Norepinephrine Bitartrate Patents

Given below is the list of patents protecting Norepinephrine Bitartrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Norepinephrine Bitartrate In 0.9% Sodium Chloride US10159657 Norepinephrine compositions and methods therefor Jan 30, 2038 Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride US10226436 Norepinephrine compositions and methods therefor Jan 30, 2038 Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride US10420735 Norepinephrine compositions and methods therefor Jan 30, 2038 Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride US10568850 Norepinephrine compositions and methods therefor Jan 30, 2038 Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride US10888534 Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags Apr 26, 2039 Inforlife
Norepinephrine Bitartrate In 0.9% Sodium Chloride US11413259 Norepinephrine compositions and methods therefor Jan 30, 2038 Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride US11602508 Norepinephrine compositions and methods therefor Jan 30, 2038 Long Grove Pharms


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Norepinephrine Bitartrate Generics

Several generic applications have been filed for Norepinephrine Bitartrate. The first generic version for Norepinephrine Bitartrate was by Meitheal Pharmaceuticals Inc and was approved on Mar 3, 2003. And the latest generic version is by Rising Pharma Holdings Inc and was approved on May 13, 2024.

Given below is the list of companies who have filed for Norepinephrine Bitartrate generic.


1. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Oct 4, 2018


2. METRICS PHARM

Metrics Pharmaceutical Ventures Llc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Metrics Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Discontinued INJECTION N/A Sep 30, 2004


3. AMNEAL

Amneal Eu Ltd has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Dec 17, 2018


4. HIKMA

Hikma Farmaceutica Portugal Sa has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Nov 7, 2018


5. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP May 6, 2021


6. RISING

Rising Pharma Holdings Inc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP May 13, 2024


7. SANDOZ

Sandoz Inc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Oct 18, 2018


8. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Mar 27, 2012


9. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Mar 3, 2003


10. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Jan 29, 2021


11. BRECKENRIDGE

Breckenridge Pharmaceutical Inc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Breckenridge.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Jan 22, 2021


12. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Nov 3, 2020


13. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Discontinued INJECTION N/A Jul 19, 2022


14. CAPLIN

Caplin Steriles Ltd has filed for 1 generic for Norepinephrine Bitartrate. Given below are the details of the strengths of this generic introduced by Caplin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML injectable Prescription INJECTION AP Sep 15, 2023